NRXS Stock Analysis: Buy, Sell, or Hold?
NRXS - Neuraxis, Inc.
$4.23
-0.42 (-9.03%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When NRXS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NRXS is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NRXS is down 13.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NRXS is currently trading at $4.23, which is considered slightly low relative to its 30-day fair value range of $4.18 to $4.87.
Technical Outlook: Technically, NRXS is in a strong uptrend. The price is currently testing key support at $4.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+18.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NRXS is in a strong uptrend. The price is currently testing key support at $4.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+18.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$4.18 -
$4.87
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding NRXS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-9.0%)
- BULLISH: Trading below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -13.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$4.18 -
$4.87
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.23
Resistance Level
$5.05
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-26.44
Wall Street Target
$5.00
(+18.2%)
Revenue Growth (YoY)
21.7%
Profit Margin
-224.2%
Last updated: January 31, 2026 9:45 PM ET
Data refreshes hourly during market hours. Next update: 10:45 PM
Data refreshes hourly during market hours. Next update: 10:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NRXS showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
Advanced NRXS Option Strategies
Professional options setups generated by AI based on today's NRXS price and gamma walls.
